Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 144 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bolt Biotherapeutics Inc | BOLT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.7608 | 06:35:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7608 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 10 | 144 | - | 0.7341 - 1.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 06:25:37 | 2 | $ 0.764 | USD |
Bolt Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.85M | 37.97M | - | 7.88M | -69.2M | -1.82 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Bolt Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BOLT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.77 | 0.81 | 0.7341 | 0.7753628 | 405,832 | -0.0092 | -1.19% |
| 1 Month | 1.12 | 1.335 | 0.7341 | 0.8695949 | 463,715 | -0.3592 | -32.07% |
| 3 Months | 1.24 | 1.56 | 0.7341 | 1.01 | 239,768 | -0.4792 | -38.65% |
| 6 Months | 0.91 | 1.56 | 0.7341 | 1.04 | 178,737 | -0.1492 | -16.40% |
| 1 Year | 1.86 | 1.86 | 0.7341 | 1.10 | 142,385 | -1.10 | -59.10% |
| 3 Years | 17.67 | 19.285 | 0.7341 | 3.97 | 207,925 | -16.91 | -95.69% |
| 5 Years | 26.10 | 43.07 | 0.7341 | 7.29 | 215,437 | -25.34 | -97.09% |
Bolt Biotherapeutics Description
| Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. |
